Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The million-molecule challenge: a moonshot project to rapidly advance longevity intervention discovery
Mitchell Lee, Benjamin W. Blue, Michael Muir, et al.
GeroScience (2023) Vol. 45, Iss. 6, pp. 3103-3113
Open Access | Times Cited: 11

Showing 11 citing articles:

Automating the practice of science: Opportunities, challenges, and implications
Sebastian Musslick, Laura Bartlett, Suyog Chandramouli, et al.
Proceedings of the National Academy of Sciences (2025) Vol. 122, Iss. 5
Open Access | Times Cited: 1
Longevity biotechnology: bridging AI, biomarkers, geroscience and clinical applications for healthy longevity
Yihua Lyu, Qiang Fu, Dominika Wilczok, et al.
Aging (2024)
Open Access | Times Cited: 8
Combining rejuvenation interventions in rodents: a milestone in biomedical gerontology whose time has come
Caitlin J. Lewis, Aubrey D.N.J. de Grey
Expert Opinion on Therapeutic Targets (2024) Vol. 28, Iss. 6, pp. 501-511
Open Access | Times Cited: 4
Mikhail ‘Misha’ Blagosklonny’s enduring legacy in geroscience: the hyperfunction theory and the therapeutic potential of rapamycin
David Barzilai
Aging (2025)
Open Access
Comprehensive evaluation of lifespan‐extending molecules in C. elegans
Grace B. Phelps, Jonas Morin, Carla M. A. Pinto, et al.
Aging Cell (2025)
Open Access
The ongoing challenge of slowing aging through drug discovery
David G. Le Couteur, Stuart L. Simpson, Victoria C. Cogger, et al.
Expert Opinion on Drug Discovery (2025)
Closed Access
Towards disease-oriented dosing of rapamycin for longevity: does aging exist or only age-related diseases?
Mikhail V. Blagosklonny
Aging (2023) Vol. 15, Iss. 14, pp. 6632-6640
Open Access | Times Cited: 10
Characterization of effects of mTOR inhibitors on aging in C. elegans
Aihan Zhang, Gadea Meecham-Garcia, Chiminh Nguyen Hong, et al.
The Journals of Gerontology Series A (2024) Vol. 79, Iss. 11
Open Access | Times Cited: 2
Gerotherapeutics: Aging Mechanism-based Pharmaceutical and Behavioral Interventions to Reduce Cancer Racial and Ethnic Disparities
Jeanne S. Mandelblatt, Michael H. Antoni, Traci N. Bethea, et al.
JNCI Journal of the National Cancer Institute (2024)
Closed Access | Times Cited: 2
Comprehensive evaluation of lifespan-extending molecules in C. elegans
Grace B. Phelps, Jonas Morin, Carla M. A. Pinto, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Optimizing preclinical models of ageing for translation to clinical trials
Sarah J. Mitchell, Michael R. MacArthur, Alice E. Kane
British Journal of Clinical Pharmacology (2023)
Open Access | Times Cited: 2
Page 1

Scroll to top